Paul W. Armstrong

Circulating Cardiac Troponin I Levels Measured by a Novel Highly Sensitive Assay in Acute Decompensated Heart Failure: Insights From the ASCEND-HF Trial.

C. O'connor, J. McMurray, P. Armstrong, 2018, Journal of cardiac failure.

Prognostic Value of Baseline and Changes in Circulating Soluble ST2 Levels and the Effects of Nesiritide in Acute Decompensated Heart Failure.

C. O'connor, J. McMurray, P. Armstrong, 2015, JACC. Heart failure.

Cost-Effectiveness of Vericiguat in Patients With Heart Failure With Reduced Ejection Fraction: The VICTORIA Randomized Clinical Trial

K. Anstrom, C. O'connor, P. Cowper, 2023, Circulation.

Diuretic use and outcomes in patients with heart failure with reduced ejection fraction: Insights from the VICTORIA trial.

A. Voors, C. McMullan, C. Westerhout, 2024, European journal of heart failure.

Hypotension During Hospitalization for Acute Heart Failure Is Independently Associated With 30-Day Mortality: Findings From ASCEND-HF

Priyesh A. Patel, V. Hasselblad, R. Califf, 2014, Circulation. Heart failure.

Recurrent Hospitalizations and Response to Vericiguat in Heart Failure and Reduced Ejection Fraction.

A. Voors, N. Sweitzer, R. Hilkert, 2024, JACC. Heart failure.

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of the Oral Soluble Guanylate Cyclase Stimulator: The VICTORIA Trial.

P. Ponikowski, K. Anstrom, Mahesh J. Patel, 2017, JACC. Heart failure.